About Anocca
Anocca is a company based in Sodertalje (Sweden) founded in 2014. It operates as a HealthTech. Anocca has raised $129.86 million across 4 funding rounds from investors including Danske Bank, Swedbank and European Investment Bank. Anocca offers products and services including TCR-T Cell Therapy. Anocca operates in a competitive market with competitors including Sana Biotechnology, Janux Therapeutics, GigaGen, Kronos Bio and Carisma Therapeutics, among others.
- Headquarter Sodertalje, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anocca Ab (Publ)
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$129.86 M (USD)
in 4 rounds
-
Latest Funding Round
$46 M (USD), Series D
Aug 19, 2025
-
Investors
Danske Bank
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anocca
Anocca offers a comprehensive portfolio of products and services, including TCR-T Cell Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
TCR-T therapies are developed for untreatable cancer targets.
Unlock access to complete
Unlock access to complete
Funding Insights of Anocca
Anocca has successfully raised a total of $129.86M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $46 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $46.0M
-
First Round
First Round
(22 Jul 2021)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series D - Anocca | Valuation | Mellby Gård | |
| May, 2023 | Amount | Series C - Anocca | Valuation | AMF , Mellby Gård | |
| Dec, 2022 | Amount | Debt – Venture - Anocca | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anocca
Anocca has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Danske Bank, Swedbank and European Investment Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Long-term value is created by Nidoco through active ownership.
|
Founded Year | Domain | Location | |
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anocca
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anocca
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anocca Comparisons
Competitors of Anocca
Anocca operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Janux Therapeutics, GigaGen, Kronos Bio and Carisma Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Chimeric antigen receptor macrophages are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of cancer and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anocca
Frequently Asked Questions about Anocca
When was Anocca founded?
Anocca was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Where is Anocca located?
Anocca is headquartered in Sodertalje, Sweden. It is registered at Sodertalje, Stockholm County, Sweden.
Is Anocca a funded company?
Anocca is a funded company, having raised a total of $129.86M across 4 funding rounds to date. The company's 1st funding round was a Debt – Venture of $26.54M, raised on Jul 22, 2021.
What does Anocca do?
Anocca is engaged in creating precision T-cell immunotherapies for untreatable cancers. Novel approaches to T-cell biology are combined with cutting-edge biotechnologies and integrated software. The primary focus is on engineering TCR-T cell therapies targeting disease markers inside cancer cells. Systematic discovery platforms and modular biotechnologies are utilized to identify therapeutic targets and build effective solutions in the oncology sector.
Who are the top competitors of Anocca?
Anocca's top competitors include Janux Therapeutics, Kronos Bio and Sana Biotechnology.
What products or services does Anocca offer?
Anocca offers TCR-T Cell Therapy.
Who are Anocca's investors?
Anocca has 8 investors. Key investors include Danske Bank, Swedbank, European Investment Bank, AMF, and Mellby Gård.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.